France Anti-Snoring Devices Market Overview, 2028

France Anti-Snoring Devices Market Overview, 2028

Snoring is a common issue that affects both individuals and their partners. Most anti-snoring devices on the market, such as mouthguards, strips, and bands, are often uncomfortable to wear. Medical technology start-ups are developing non-invasive anti-snoring devices to address this issue. When the sound of snoring is detected, these devices gently move the snorer's head to restore normal breathing and stop snoring. There is growing awareness in France of the health risks associated with snoring, such as sleep apnea, cardiovascular disease, and stroke. This is leading more individuals to seek out anti-snoring devices to improve their sleep quality and reduce their risk of developing these health issues. Furthermore, the anti-snoring device market in France is characterized by a wide range of innovative products, such as custom-fit mouthpieces and nasal devices, high-tech smart beds, and sleep tracking apps. These products are driving demand and helping to expand the market. Moreover, France has an aging population, with a large number of adults over the age of 65. Snoring and sleep apnea become more common as individuals age, which is contributing to the growth of the anti-snoring device market.

According to the research report ""France Anti-Snoring Market Overview, 2028,"" published by Bonafide Research, the France Anti-Snoring market was valued at more than USD 65 Million in 2022. The French healthcare industry is expanding as a result of an ageing population and increased demand for healthcare services. As healthcare providers seek effective solutions to improve patient outcomes, this is opening up new opportunities for companies to develop and market anti-snoring devices. Furthermore, France's fast-paced, stressful lifestyle can contribute to sleep issues and snoring. Anti-snoring devices are becoming more popular as people look for ways to improve their sleep quality. Furthermore, obesity is a major risk factor for snoring and sleep apnea, and obesity is becoming more common in France. This is contributing to the growth of the anti-snoring device market, as more people look for ways to sleep better.

In France, 3D printing technology is becoming increasingly popular among manufacturers of anti-snoring devices. This technology enables the development of custom-fit mouthpieces and nasal devices that are more comfortable and effective than standard products. In addition to improving comfort, 3D printing has the potential to improve the effectiveness of anti-snoring devices. Manufacturers can ensure that they are providing the proper amount of support and positioning to the airway by creating custom-fit devices, which helps to prevent snoring and improve breathing during sleep. Narval by ResMed, ProSomnus, SOMNICS, and other manufacturers of anti-snoring devices in France that use 3D printing technology include Narval by ResMed, ProSomnus, SOMNICS, and others.

Based on product type, the market is segmented into mandibular advancement devices, nasal devices, position control devices, chin straps, EPAP/CPAP, and tongue stabilizing devices. In the France market, MADs have the largest market share among the various types of anti-snoring and sleep apnea devices. This is due to their effectiveness, ease of use, and comfort for patients. MADs are typically custom-fitted to each patient's mouth by a dentist or sleep specialist. Furthermore, One advantage of MADs is that they are relatively non-invasive compared to other sleep apnea treatments, such as surgery or continuous positive airway pressure (CPAP) therapy. MADs are also portable and easy to use, making them a convenient option for people who travel frequently. EPAP/CPAP is expected to grow at a higher CAGR during the forecast period. This is due to the increasing prevalence of sleep apnea in the region, as well as the growing awareness among patients and healthcare providers about the benefits of EPAP/CPAP therapy. The market is divided into hospital, clinic, retail pharmacy, and e-commerce segments based on the distribution channel. Hospitals typically treat a wide range of patients with different health conditions, including those with sleep disorders. Therefore, hospitals may have a larger pool of potential anti-snoring device users than other distribution channels, which could lead to higher sales growth. Moreover, many anti-snoring devices may be covered by health insurance, and hospitals may be more likely to have relationships with insurers or be better equipped to handle insurance claims. This could make hospitals a more attractive distribution channel for patients seeking to obtain anti-snoring devices through insurance coverage. E-commerce has the highest CAGR for the distribution of anti-snoring devices. E-commerce channels have the potential to reach a larger audience than physical retail stores or hospitals. This is because consumers can purchase anti-snoring devices from anywhere with an internet connection, allowing companies to expand their reach to rural areas or regions where physical stores may be scarce. Furthermore, E-commerce channels often provide customer reviews and ratings for products, which can help build trust and confidence in the product among potential buyers.

The first anti-snoring device was invented in France in the 1920s by a dentist named Pierre Robin. Robin's device was a metal frame with a mouthpiece that held the tongue in place, preventing it from falling back and blocking the airway during sleep. Furthermore, one of the most well-known French anti-snoring devices is the Narval by ResMed, which was introduced in the early 2000s. The Narval is a mandibular repositioning device that is custom-made for each patient using 3D printing technology. The device is designed to hold the lower jaw in a slightly forward position during sleep, which helps to keep the airway open and reduce snoring. Moreover, another French company that has made significant contributions to the field of anti-snoring devices is SomnoMed. SomnoMed was founded in 2004 and has since become a leading manufacturer of custom-made oral appliances for the treatment of snoring and sleep apnea. Their devices are designed to be comfortable, effective, and easy to use, and they have been approved by various regulatory agencies in France and around the world.

In France, the government has recognized the importance of treating snoring and sleep apnea, which can lead to serious health consequences if left untreated. As a result, the French government has implemented several initiatives aimed at promoting the development and use of anti-snoring devices. Furthermore, one of the initiatives is the reimbursement of certain anti-snoring devices by the French national health insurance system. The reimbursement covers a range of devices, including mandibular advancement devices, tongue stabilizing devices, and nasal dilators. To be eligible for reimbursement, the device must be prescribed by a physician and meet certain criteria. Moreover the government provides funding for research projects aimed at developing new devices and improving the effectiveness of existing ones.

Developments:
• SOMNICS launched a new tongue stabilizing device in 2021 called ""Silensor-T."" The device is designed to hold the tongue in place during sleep, preventing it from falling back and blocking the airway.
• Airway Technologies introduced a new anti-snoring device called ""Rythmic"" in 2021. The device uses a small, lightweight sensor to monitor the wearer's breathing and detect snoring. When snoring is detected, the device vibrates gently, prompting the wearer to change position and reduce snoring.

Considered in this report
• Geography: France
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report
• France Anti-Snoring market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Mandibular Advancement Device
• Nasal Device
• Position Control Device
• Chin Straps
• EPAP/CPAP
• Tongue Stabilizing

By Distribution Chanel:
• Hospitals
• Clinics
• Retail Pharmacies
• E-commerce
• Others

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, government-generated reports, and databases. After gathering the data from secondary sources, primary research was conducted by making telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started doing primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations and organizations related to the Anti Snoring Device industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.